Candesartan CAS 139481-59-7 Bohloeki >99.0% (HPLC) Factory

Tlhaloso e Khutšoanyane:

Lebitso la lik'hemik'hale: Candesartan

CAS: 139481-59-7

Bohloeki: >99.0% (HPLC)

Ponahalo: Phofo e tšoeu

Mohanyetsi ea khethiloeng oa Angiotensin II Receptor

Boleng bo Phahameng, Tlhahiso ea Khoebo

E-Mail: alvin@ruifuchem.com


Lintlha tsa Sehlahisoa

Lihlahisoa tse Amanang

Li-tag tsa Sehlahisoa

Tlhaloso:

Lintho tsa Lik'hemik'hale:

Lebitso la Lik'hemik'hale Candesartan
Litlhaloso tse tšoanang CV-11974;2-Ethoxy-1-[[2'- (1H-tetrazol-5-yl) [1,1'-biphenyl] -4-yl]methyl] -1H-Benzimidazole-7-Carboxylic Acid;3- [[2'- (1H-Tetrazol-5-yl) biphenyl-4-yl]methyl]-2-ethoxy-3H-Benzimidazole-4-Carboxylic Acid;Candesartan M1;Candesartan Cilexetil EP Impurity G
Nomoro ea CAS 139481-59-7
Nomoro ea KAtse RF-PI1889
Boemo ba Setoko Ka Setokong, Sekhahla sa Tlhahiso Ho fihlela ho Lithane
Foromo ea limolek'hule Setšoantšo sa C24H20N6O3
Boima ba Molek'hule 440.45
Brand Ruifu Chemical

Litlhaloso:

Ntho Litlhaloso
Ponahalo Phofo e Tshweu
Identification-HPLC Nako ea ho Boloka e Tšoanang le Standard
Boitsebiso-IR E ts'oanang le Standard
Mokhoa oa Bohloeki / Analysis >99.0% (HPLC)
Melting Point 183.0 ~ 185.0 ℃
Tahlehelo ka ho Omisa <0.50%
Mongobo (KF) <0.50%
Masalla a ho Ignition <0.50%
Litšepe tse boima <20ppm
Tšilafalo ea Motho ka Mong <1.00% (HPLC)
Litšila ka Kakaretso <1.00% (HPLC)
Refractive Index n20/D 1.745~1.747
Tekanyetso ea Teko Maemo a Khoebo
Tšebeliso API;Bakeng sa Phekolo ea Khatello ea mali

Sephutheloana le Bobolokelo:

Sephutheloana: Botlolo, Aluminium foil bag, 25kg/Cardboard Drum, kapa ho ea ka tlhokahalo ea moreki.

Boemo ba polokelo:Boloka ka lijaneng tse koetsoeng sebakeng se phodileng le se omileng;Sireletsa leseli le mongobo

Melemo:

1

LBH:

Kopo:

Candesartan (CAS: 139481-59-7) ke mohanyetsi oa angiotensin II receptor le IC50 ea 0.26 nM.Sepheo: Angiotensin II Receptor candesartan e bontšoa bakeng sa kalafo ea khatello ea mali.Candesartan Cilexetil e ile ea amoheloa ka lekhetlo la pele ka GB ka la 29 Apr, 1997, eaba ea amoheloa ke US Food and Drug Administration (FDA) ka June 4, 1998, 'me ea amoheloa ke Pharmaceuticals and Medical Devices Agency of Japan (PMDA) ka Mar 12, 1999. E hlahisitsoe ke AstraZeneca, ea ntan'o rekisoa e le Atacand ke AstraZeneca ka GB le US, 'me ea rekisoa e le Blopress ke Takeda ho JP.Candesartan Cilexetil ke angiotensin II receptor blocker (ARB), e thibela vasoconstrictor le litlamorao tsa aldosterone-secreting ea angiotensin II ka ho thibela ka boikhethelo tlamo ea angiotensin II ho receptor ea AT1 liseleng tse ngata, joalo ka mesifa e boreleli ea methapo le tšoelesa ea adrenal.Atacand e bontšoa bakeng sa phekolo ea khatello ea mali ho batho ba baholo le bana ba lilemo tse 1 ho isa ho tse <17, ho hloleha ha pelo (NYHA sehlopha sa II-IV) le ho sebelisoa ho fokotsa lefu la pelo le lefu la pelo le ho kena sepetlele.

Ngola molaetsa wa hao mona mme o re romele wona